Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluation.
- DOI
- 10.1016/j.drugpo.2026.105174
- Published
- 2026 Apr
- Container
- The International journal on drug policy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drugpo.2026.105174,
title = {Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluation.},
author = {McCulloch P and Family H and Shaw A and Vojt G and Gilchrist G and Matheson C and Maxwell M and Neale J and Myring G and McLeod H and Hickman M and Vickerman P and Munro A and MacGillivray S},
year = {2026},
journal = {The International journal on drug policy},
doi = {10.1016/j.drugpo.2026.105174},
url = {https://doi.org/10.1016/j.drugpo.2026.105174}
}RIS
TY - JOUR TI - Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluation. AU - McCulloch P AU - Family H AU - Shaw A AU - Vojt G AU - Gilchrist G AU - Matheson C AU - Maxwell M AU - Neale J AU - Myring G AU - McLeod H AU - Hickman M AU - Vickerman P AU - Munro A AU - MacGillivray S PY - 2026 JO - The International journal on drug policy DO - 10.1016/j.drugpo.2026.105174 UR - https://doi.org/10.1016/j.drugpo.2026.105174 ER -
APA
P, M., H, F., A, S., G, V., G, G., C, M., M, M., J, N., G, M., H, M., M, H., P, V., A, M., & S, M. (2026). Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluation.. The International journal on drug policy. https://doi.org/10.1016/j.drugpo.2026.105174
Source records
- pubmed · retrieved 2026-09-26T07:05:28.068Z